<strong>Nexpoint Asset Management Q2 2026 Portfolio Activity: Significant Buys & Sells</strong>

Nexpoint Asset Management LP reported its portfolio activity for the period ending June 30, 2026. The fund's total value stands at $143,135,224, with holdings spread across various sectors as detailed in their allocations.

Key Purchases This Quarter

This quarter, Nexpoint Asset Management demonstrated active buying behavior, significantly increasing its portfolio weightings. The fund notably NUVALENT INC (NUVL), adding 617,820 shares representing a brand-new position now accounting for approximately $5.1% of the total portfolio value.

Furthermore, Nexpoint significantly boosted its stake in GLOBAL BUSINESS TRAVEL GROUP (GBTG), acquiring 8,089,339 shares which constituted a full position this quarter. The fund also made substantial additions to other existing holdings:

• ESSENTIAL UTILS INC (WTRG): Acquired 1,780,349 shares.
• CATALYST PHARMACEUTICALS INC (CPRX): Acquired 1,602,557 shares.
• AVANOS MED INC (AVNS): Acquired 2,177,366 shares.

In addition to these large acquisitions forming new or significantly expanded positions, the fund also increased its holdings in several other stocks:

• SILA REALTY TRUST INC (SILA) saw an increase.
• JANUS HENDERSON GROUP PLC (JHG) increased its position by a notable percentage.

Notable Sales and Portfolio Adjustments

Conversely, Nexpoint Asset Management also showed significant selling activity during this quarter. The fund disposed of all shares in MIDD, a move that removed the entire position from its portfolio.

The most substantial reduction was observed with respect to CATALYST PHARMACEUTICALS INC (CPRX). The fund sold 1,602,557 shares of this stock, completely exiting the position.

Other significant exits or reductions include:

• SIGNIFICANT SELL: MIDD - Entire position liquidated.
• TALKSPACE INC (TALK): The fund sold a large number of shares, reducing the holding significantly or exiting it entirely. This resulted in a substantial percentage decrease for this stock within the portfolio.

Additionally, Nexpoint made adjustments to other holdings:

• ORGANON & CO (OGN): Acquired a new position or increased an existing one.

Overall Portfolio Strategy and Insights

The portfolio activity for Nexpoint Asset Management in Q2 2026 highlights a dynamic investment approach focused on capitalizing on growth opportunities while strategically exiting positions. The quarter saw substantial buying power deployed, particularly evident through the establishment of new large positions like NUVALENT INC (NUVL) and the significant increase in holdings for GLOBAL BUSINESS TRAVEL GROUP (GBTG).

The fund's actions suggest a focus on acquiring undervalued or growth-oriented assets, as indicated by the 100% share increases for several holdings including TAYLOR MORRISON HOME CORP (TMHC), ESSENTIAL UTILS INC (WTRG), and others. This influx of shares likely aims to boost portfolio diversification or target specific sectors for performance enhancement.

Simultaneously, the decision to sell a large portion of CATALYST PHARMACEUTICALS INC (CPRX), effectively exiting that position entirely, and the complete removal of MIDD indicate a review or rotation strategy. The fund may be reallocating capital based on performance expectations, risk assessment, or market opportunities perceived elsewhere.

The overall pattern points to Nexpoint actively managing its portfolio composition throughout the quarter, balancing new investments with exits of substantial holdings like MIDD. This strategic buying and selling activity is characteristic of a fund manager seeking optimal returns by adapting positions to changing market dynamics.